Report cover image

China Medical Plastics Market Size, Share, Trends, Industry Analysis Report By Polymer Type (Thermoplastics, Elastomers, Biodegradable Polymers, Others), By Application, By Manufacturing – Market Forecast, 2025–2034

Publisher Polaris Market Research & Consulting LLP
Published Aug 01, 2025
Length 128 Pages
SKU # PLRS20381569

Description

The china medical plastics market size is expected to reach USD 5,466.93 million by 2034, according to a new study by Polaris Market Research. The report “China Medical Plastics Market Size, Share, Trends, Industry Analysis Report By Polymer Type (Thermoplastics, Elastomers, Biodegradable Polymers, Others), By Application, By Manufacturing – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The China medical plastics market is characterized by high-volume manufacturing, rapid technology adoption, and growing sophistication in medical device applications. Demand for medical-grade plastics is being driven by expanding healthcare access, increasing prevalence of chronic conditions, and strong momentum in localized production of diagnostic and therapeutic equipment. Manufacturers are scaling operations to meet rising needs for disposable and durable components across hospitals, clinics, and home care settings. The market is witnessing strong integration of automation, AI, and data-driven quality control to streamline plastic component production. Growth is supported by public and private investments in medical infrastructure and device innovation, which has increased the need for cost-efficient, compliant polymer materials. Trends highlight the shift toward advanced thermoplastics, antimicrobial polymers, and sterilization-compatible blends used in both invasive and noninvasive applications.

Opportunities are emerging in the development of bioresorbable plastics, flexible electronics housing, and lightweight enclosures for portable medical devices. Strong policy support for innovation and domestic self-reliance is encouraging vertical integration and material development tailored to regulatory and clinical standards. Industry participants are also focusing on improving the recyclability and environmental footprint of medical plastic products in response to sustainability goals. Collaborations between research institutes and manufacturers are helping drive material breakthroughs and accelerate commercialization. Continuous improvement in extrusion, molding, and co-polymerization processes is further enhancing the functional capabilities of plastics. The market is becoming a critical enabler of China’s goal to expand advanced healthcare access while improving the performance and safety of next-generation medical technologies.

China Medical Plastics Market Report Highlights

By polymer type, the thermoplastics segment accounted for the largest revenue share of ~72.4% in 2024 due to their adaptability in precision manufacturing and compliance with stringent EU medical standards.

By application, the medical disposable segment is projected to register a CAGR of 7.0% from 2025 to 2034 due to rising emphasis on hygiene, safety, and efficiency in care delivery.

A few key players include SABIC, Dow, BASF, Covestro AG, Solvay, Evonik Industries AG, Celanese Corporation, Eastman Chemical Company, DSM-Firmenich, Kraton Corporation, LG Chem, and Sinopec.

Polaris Market Research has segmented the China medical plastics market report on the basis of polymer type, application, and manufacturing:

By Polymer Type Outlook (Revenue, USD Million, 2020–2034)

Thermoplastics

Polypropylene (PP)

Polyvinyl Chloride (PVC)

Polyethylene (PE)

Polycarbonate (PC)

Polyurethane

Acrylonitrile Butadiene Styrene (ABS)

Others

Elastomers

Biodegradable Polymers

Others

By Application Outlook (Revenue, USD Million, 2020–2034)

Medical Instruments & Devices

Medical Disposable

Diagnostic Instruments & Tools

Others

By Manufacturing Outlook (Revenue, USD Million, 2020–2034)

Extrusion Tubing

Injection Molding

Compression Molding

Other

Table of Contents

128 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Source
3.2.1. Primary Source
3.2.2. Secondary Source
4. China Medical Plastics Market Insights
4.1. China Medical Plastics Market – Market Snapshot
4.2. China Medical Plastics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Expansion of Geriatric Healthcare Infrastructure
4.2.1.2. Strategic Collaborations in Medical Plastics
4.2.2. Restraints and Challenges
4.2.2.1. Stringent environmental regulations on plastic use and recycling create compliance challenges for manufacturers
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. China Medical Plastics Market Trends
4.6. Value Chain Analysis
5. China Medical Plastics Market, by Polymer Type
5.1. Key Findings
5.2. Introduction
5.2.1. China Medical Plastics Market, by Polymer Type, 2020-2034 (USD Million)
5.3. Thermoplastics
5.3.1. China Medical Plastics Market, by Thermoplastics, 2020-2034 (USD Million)
5.3.2. Polypropylene (PP)
5.3.2.1. China Medical Plastics Market, by Polypropylene (PP), 2020-2034 (USD Million)
5.3.3. Polyvinyl Chloride (PVC)
5.3.3.1. China Medical Plastics Market, by Polyvinyl Chloride (PVC), 2020-2034 (USD Million)
5.3.4. Polyethylene (PE)
5.3.4.1. China Medical Plastics Market, by Polyethylene (PE), 2020-2034 (USD Million)
5.3.5. Polycarbonate (PC)
5.3.5.1. China Medical Plastics Market, by Polycarbonate (PC), 2020-2034 (USD Million)
5.3.6. Polyurethane
5.3.6.1. China Medical Plastics Market, by Polyurethane, 2020-2034 (USD Million)
5.3.7. Acrylonitrile Butadiene Styrene (ABS)
5.3.7.1. China Medical Plastics Market, by Acrylonitrile Butadiene Styrene (ABS), 2020-2034 (USD Million)
5.3.8. Others
5.3.8.1. China Medical Plastics Market, by Others, 2020-2034 (USD Million)
5.4. Elastomers
5.4.1. China Medical Plastics Market, by Elastomers, 2020-2034 (USD Million)
5.5. Biodegradable Polymers
5.5.1. China Medical Plastics Market, by Biodegradable Polymers, 2020-2034 (USD Million)
5.6. Others
5.6.1. China Medical Plastics Market, by Others, 2020-2034 (USD Million)
6. China Medical Plastics Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. China Medical Plastics Market, by Application, 2020-2034 (USD Million)
6.3. Medical Instruments & Devices
6.3.1. China Medical Plastics Market, by Medical Instruments & Devices, 2020-2034 (USD Million)
6.4. Medical Disposables
6.4.1. China Medical Plastics Market, by Medical Disposables, 2020-2034 (USD Million)
6.5. Diagnostic Instruments & Tools
6.5.1. China Medical Plastics Market, by Diagnostic Instruments & Tools, 2020-2034 (USD Million)
6.6. Others
6.6.1. China Medical Plastics Market, by Others, 2020-2034 (USD Million)
7. China Medical Plastics Market, by Manufacturing
7.1. Key Findings
7.2. Introduction
7.2.1. China Medical Plastics Market, by Manufacturing, 2020-2034 (USD Million)
7.3. Extrusion Tubing
7.3.1. China Medical Plastics Market, by Extrusion Tubing, 2020-2034 (USD Million)
7.4. Injection Molding
7.4.1. China Medical Plastics Market, by Injection Molding, 2020-2034 (USD Million)
7.5. Compression Molding
7.5.1. China Medical Plastics Market, by Compression Molding, 2020-2034 (USD Million)
7.6. Others
7.6.1. China Medical Plastics Market, by Others, 2020-2034 (USD Million)
8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
9.1. BASF
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Development
9.2. Celanese Corporation
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Development
9.3. Covestro
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Development
9.4. Dow
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Development
9.5. dsm-firmenich
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Development
9.6. Eastman Chemical Company
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Development
9.7. Evonik Industries AG
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Development
9.8. Kraton Corporation
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Recent Development
9.9. LG Chem
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Recent Development
9.10. SABIC
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Recent Development
9.11. Sinopec
9.11.1. Company Overview
9.11.2. Financial Performance
9.11.3. Product Benchmarking
9.11.4. Recent Development
9.12. Solvay
9.12.1. Company Overview
9.12.2. Financial Performance
9.12.3. Product Benchmarking
9.12.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us